Wells Fargo’s Halozyme HALO Stock Holding History

Wells Fargo’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,500	Closed	-$1K	–	6430
2019 Q4	$1K	Buy	+8,500	New	+$147K	﹤0.01%	6249
2017 Q3	–	Sell	-13,700	Closed	-$5K	–	6367
2017 Q2	$5K	Buy	+13,700	New	+$183K	﹤0.01%	5917
2016 Q3	–	Sell	-280,300	Closed	-$91K	–	6244
2016 Q2	$91K	Buy	280,300 +18,100	+7%	+$179K	﹤0.01%	4889
2016 Q1	$326K	Buy	+262,200	New	+$2.47M	﹤0.01%	4126

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's HALO Position: Q1 2026 in Review

Wells Fargo increased its Halozyme (HALO) stake by 9.3% in Q1 2026, buying an estimated $9.18M and bringing the position to 1,535,737 shares worth $99.3M. The position accounts for 0.02% of the portfolio, ranked #633.

Wells Fargo first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Wells Fargo held 1,535,737 shares of Halozyme worth $99.3M as of Q1 2026.
Wells Fargo bought 130,220 Halozyme shares in Q1 2026, an estimated $9.18M.
Halozyme made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #633 holding.
Wells Fargo first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.